Home > Financial Ratios > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for SUVEN PHARMACEUTICALS
Please provide your vote to see the results

SUVEN PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) -7.9947.4313.49134.02-

What is the latest Core EBITDA Growth ratio of SUVEN PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SUVEN PHARMACEUTICALS is -7.99 based on Mar2023 Consolidated results.
Year Core EBITDA Growth
Mar2023-7.99
Mar202247.43
Mar202113.49
Mar2020134.02
Mar2019-

How is Core EBITDA Growth of SUVEN PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2023 -7.99
Negative
Mar2022 47.43
251.59
Mar2021 13.49
-89.93
Mar2020 134.02
0
Mar2019 0 -

Other Financial Ratios of SUVEN PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹16,880.0 Cr 2.9% 0.7% 42.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,026.0 Cr 0.5% -5.7% 55.1% Stock Analytics
CIPLA ₹114,925.0 Cr 1.1% -4.4% 55.5% Stock Analytics
DIVIS LABORATORIES ₹105,128.0 Cr -0.7% 9.4% 21.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,109.0 Cr 0.1% 1.1% 28.1% Stock Analytics
ZYDUS LIFESCIENCES ₹102,736.0 Cr 6% 2.8% 93.1% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

2.9%

0.7%

42.9%

SENSEX

0.2%

-0.2%

20.9%


You may also like the below Video Courses